Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment. - Archive ouverte HAL Access content directly
Journal Articles Bone Marrow Transplantation Year : 2010

Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment.

(1, 2) , (3) , (4) , (5) , (6) , (7) , (1, 2) , (1, 2)
1
2
3
4
5
6
7

Abstract

Remissions of haematological malignancies have been reported after allo-SCT, despite donor cell rejection, suggesting that sustained allogeneic engraftment is not mandatory to obtain a lasting anti-tumour effect. To evaluate the potential benefit from transient post-allo-SCT alloreactivity, we took advantage of the Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC) registry to colligate 14 patients with an efficient and long-lasting allogeneic (GVL) effect after allo-SCT for haematological malignancies, despite transient or absent engraftment. None received a second allogeneic graft after autologous recovery. The median duration of remission after autologous reconstitution was 118 (12-252) months. Although we cannot exclude the possibility that some patients were cured before allo-SCT, this retrospective analysis does strongly suggest that an efficient GVL effect can be observed without sustained donor engraftment, and that the transient presence of donor T cells might be sufficient to induce a powerful GVL effect.
Not file

Dates and versions

inserm-00484316 , version 1 (18-05-2010)

Identifiers

Cite

E. Daguindau, B. Lioure, A. Buzyn, M. Robin, C. Faucher, et al.. Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment.. Bone Marrow Transplantation, 2010, 45 (1), pp.177-80. ⟨10.1038/bmt.2009.96⟩. ⟨inserm-00484316⟩
52 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More